Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209 – 49.
Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, et al. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017;241(3):375–91.
Article CAS PubMed Google Scholar
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10.
Article CAS PubMed Google Scholar
Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast Cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160–7.
Article PubMed PubMed Central Google Scholar
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817–26.
Article CAS PubMed Google Scholar
Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.
Acs B, Fredriksson I, Rönnlund C, Hagerling C, Ehinger A, Kovács A et al. Variability in breast Cancer Biomarker Assessment and the Effect on Oncological Treatment decisions: a Nationwide 5-Year Population-based study. Cancers [Internet]. 2021; 13(5).
Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, et al. An international Ki67 reproducibility study. J Natl Cancer Inst. 2013;105(24):1897–906.
Article PubMed PubMed Central Google Scholar
Okimoto LYS, Mendonca-Neto R, Nakamura FG, Nakamura EF, Fenyö D, Silva CT. Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification. BMC Bioinformatics. 2024;25(1):92.
Article PubMed PubMed Central Google Scholar
Ciriello G, Gatza Michael L, Beck Andrew H, Wilkerson Matthew D, Rhie Suhn K, Pastore A, et al. Comprehensive molecular portraits of invasive lobular breast Cancer. Cell. 2015;163(2):506–19.
Article CAS PubMed PubMed Central Google Scholar
Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene. 2010;29(31):4369–77.
Article CAS PubMed PubMed Central Google Scholar
Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast Cancer. Clin Cancer Res. 2010;16(21):5222–32.
Article CAS PubMed PubMed Central Google Scholar
Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast Cancer working group. J Natl Cancer Inst. 2011;103(22):1656–64.
Article CAS PubMed PubMed Central Google Scholar
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133(4):1710–5.
Article CAS PubMed Google Scholar
Niikura N, Iwamoto T, Masuda S, Kumaki N, Xiaoyan T, Shirane M, et al. Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci. 2012;103(8):1508–12.
Article CAS PubMed PubMed Central Google Scholar
Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. Ki-67 as a prognostic biomarker in invasive breast Cancer. Cancers (Basel). 2021;13:17.
Ström P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020;21(2):222–32. https://doi.org/10.1016/S470-2045(19)30738-7. Epub 2020 Jan 8.
Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Fenyö D, et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nat Med. 2018;24(10):1559–67.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Ali MA, Vallon-Christersson J, Humphreys K, Hartman J, Rantalainen M. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information. Eur J Cancer. 2023;191:112953.
Article CAS PubMed Google Scholar
Wang Y, Kartasalo K, Weitz P, Ács B, Valkonen M, Larsson C, et al. Predicting Molecular Phenotypes from Histopathology images: a transcriptome-wide expression-morphology analysis in breast Cancer. Cancer Res. 2021;81(19):5115–26.
Article CAS PubMed PubMed Central Google Scholar
Schmauch B, Romagnoni A, Pronier E, Saillard C, Maillé P, Calderaro J, et al. A deep learning model to predict RNA-Seq expression of tumours from whole slide images. Nat Commun. 2020;11(1):3877.
Article CAS PubMed PubMed Central Google Scholar
Mondol RK, Millar EKA, Graham PH, Browne L, Sowmya A, Meijering E. Hist2RNA: an efficient Deep Learning Architecture to Predict Gene expression from breast Cancer histopathology images. Cancers (Basel). 2023;15(9).
Veta M, Heng YJ, Stathonikos N, Bejnordi BE, Beca F, Wollmann T, et al. Predicting breast tumor proliferation from whole-slide images: the TUPAC16 challenge. Med Image Anal. 2019;54:111–21.
Wang M, Klevebring D, Lindberg J, Czene K, Grönberg H, Rantalainen M. Determining breast cancer histological grade from RNA-sequencing data. Breast Cancer Res. 2016;18(1):48.
Article PubMed PubMed Central Google Scholar
Rantalainen M, Klevebring D, Lindberg J, Ivansson E, Rosin G, Kis L, et al. Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers. Sci Rep. 2016;6:38037.
Article CAS PubMed PubMed Central Google Scholar
Staaf J, Häkkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. npj Breast Cancer. 2022;8(1):94.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Acs B, Robertson S, Liu B, Solorzano L, Wählby C et al. Improved breast cancer histological grading using deep learning. Ann Oncol. 2022.
Goode A, Gilbert B, Harkes J, Jukic D, Satyanarayanan M. OpenSlide: a vendor-neutral software foundation for digital pathology. J Pathol Inf. 2013;4:27.
Macenko M, Niethammer M, Marron JS, Borland D, Woosley JT, Guan X, et al. editors. A method for normalizing histology slides for quantitative analysis. 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro; 2009 28 June-1 July 2009.
Pech-Pacheco JL, Cristobal G, Chamorro-Martinez J, Fernandez-Valdivia J, editors. Diatom autofocusing in brightfield microscopy: a comparative study. Proceedings 15th International Conference on Pattern Recognition ICPR-2000; 2000 3–7 Sept. 2000.
Szegedy C, Vanhoucke V, Ioffe S, Shlens J, Wojna Z, editors. Rethinking the Inception Architecture for Computer Vision. 2016 IEEE Conference on Computer Vision and Recognition P. (CVPR); 2016 27–30 June 2016.
Aleskandarany MA, Green AR, Benhasouna AA, Barros FF, Neal K, Reis-Filho JS, et al. Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer. Breast Cancer Res. 2012;14(1):R3.
Article PubMed PubMed Central Google Scholar
Beresford MJ, Wilson GD, Makris A. Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res. 2006;8(6):216.
Article PubMed PubMed Central Google Scholar
Aubreville M, Stathonikos N, Bertram CA, Klopfleisch R, ter Hoeve N, Ciompi F, et al. Mitosis domain generalization in histopathology images — the MIDOG challenge. Med Image Anal. 2023;84:102699.
Penault-Llorca F, Radosevic-Robin N. Ki67 assessment in breast cancer: an update. Pathology. 2017;49(2):166–71.
Article CAS PubMed Google Scholar
Jones RL, Salter J, A’Hern R, Nerurkar A, Parton M, Reis-Filho JS, et al. Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2010;119(2):315–23.
留言 (0)